Skip to main content

Pharma & Biotech

Collagen Solutions confirms it could be sold, broken up or refinanced

The group said its management will now engage with interested parties in a constructive and positive manner

Collagen Solutions PLC (LON:COS) has revealed that several options remain open as its formal sales process continues, including the sale of the company.

In a regulatory statement, the group told investors that it received indications of interest for a potential purchase of the whole company, a potential purchase of part of the business, and a refinancing of the company.

READ: Collagen highlights positive revenue across businesses despite COVID-19

“The company looks forward to engaging with relevant parties in a constructive and positive manner with a view to optimising value for shareholders,” Collagen said.

But, it added: “There can be no certainty that an offer will be made, nor as to the terms on which any offer will be made, or that any transaction will ensue.”

A formal sales process was launched on April 16 when the group appointed Goodbody Stockbroker as its joint financial adviser.

The company had a deadline of May 15 for intentions of interest to be submitted from third parties.